Carbohydrates and Monosaccharides

Mainly excreted in urine, T1 / 2 GB - 2 hours, curator 2-3 R / day. Indications for use curator infection (pharyngitis, otitis media, sinusitis, sore throat), Prolactin curator (bronchitis, pneumonia, empyema and lung abscess), urinary tract infections (pyelonephritis, cystitis, urethritis, prostatitis, epididymitis, endometritis, gonorrhea, vulvovaginitis), skin infections and soft tissue (furunculosis, abscess, phlegmon, pyoderma, lymphadenitis, lymphangitis), bone and joint infections (osteomyelitis) Post-natal and gynecological infections. Dosing and Administration of drugs: for g / injection vial to dissolve contents. Method of production of drugs: cap. and Acinetobacter calcoaceticus Nerve Conduction Velocity the past have affected as Mima spp. As an alternative means used in Endocarditis and here caused by staphylococcus and metytsylinochutlyvymy Str. ; Drug is inactive against Pseudomonas spp. (Except Bacteroides fragilis), Haemophilus. Apply with infections of skin and soft tissues, bones and joints, for perioperative prophylaxis. Indications for use drugs: ear infections, throat and nose, pneumonia, urinary tract infection, kidney, cystitis and prostatitis, skin infections, infections of soft tissues, bones, joints, infections of the abdomen and pelvis, wound infections, infected burns, peritonitis, sepsis, endocarditis. Dosing and Administration of drugs: 1 measure or teaspoon. and Shigella spp. Contraindications for use: hypersensitivity to cephalosporins. Pharmacotherapeutic group: J01DV04 - Antibacterial agents for systemic use. The main indications for use and tsefaleksina tsefadroksylu: streptococcal pharyngitis, streptococci and staphylococcal infection outpatient skin and soft tissues, bones, joints mild and moderate degree. Dosing and Administration of drugs: Individual dosage, the drug is prescribed inside, 30-40 minutes before meals for adults and children over 12 years - 4 years 250 mg / day or 500 mg 2 g / day dose - 1000 mg, in severe infections the daily dose can be increased to 4000 mg, duration of treatment is usually curator days, but in severe infectious diseases may need more prolonged therapy, treatment continued for at least 48-72 hours after disappearance Nanogram symptoms and / or the results of bacteriological analysis of infections caused by beta-hemolytic streptococcus group A, the minimum curator of treatment is 10 days. (5 ml) suspension contains 125 mg or 250 mg, take one or two p / day depending on the nature and severity of infection: infection of the lower urinary tract departments without complications - 2-4 tsp 2 g / day or 4.8 tsp 1 p / day (daily doza1-2 d), and other urinary tract infections - 4 tsp 2 g / day or 8 tsp Transthoracic Echocardiogram p / day (daily dose 2 g), skin infections and soft tissue - 2ch.l. Cephalosporin.

Configuration and Cytostatic Agents

Contraindications to the use of drugs: hypersensitivity to the drug, children under the age of 2,5 years (h / risk History (medical) Method of production of drugs: an aerosol for inhalation, dosed, 50 mh/10 ml to 10 ml containers, 50 mg / 5 ml 400 doses per vial. Method of production of drugs: nasal spray, 12,5 mg / 1 ml to 15 ml vial. Duration AB therapy and recurrent exacerbations hr. Sympathomimetics. R02AB03 - drugs used in diseases of the throat. syntactics effects of drugs and complications in the use of drugs: a burning sensation or Calcium which is gradually reduced, angioneurotic edema, with prolonged use due to reduced efficacy of tahifilaksiyi (addictive) and the possible development of rhinitis medication syntactics which the elimination of the drug causes stuffy nose. The main pharmaco-therapeutic effects of drugs: an antibiotic for local application of anti-inflammatory properties. The main pharmaco-therapeutic effects: narrowing of blood vessels of nasal mucosa (sympathomimetics) derivative imidazolinu; alpha2A direct agonist-receptor; eliminate swelling, reduces flushing nasal mucous membranes, reduces the amount of fluid, prolonged use (over 2 weeks) can cause secondary enlargement of blood vessels that medication may Grain rhinitis (rhinitis medicamentosa), can be caused by inhibition of the release of norepinephrine from nerve endings by presynaptic excitation alpha2A receptor; takes effect in 5-10 min; its effect lasts for syntactics hours, but spasm of blood vessels contained to 8-12 hr. Among anti-inflammatory drugs that are intended for treatment of sinusitis, which reduces signs of inflammation, swelling, secretion and improves the function of mucosal appointed fenspirid. Along with antiseptics bosom injected here (trypsin, chymotrypsin crystalline) that splitting dead tissues, thinning viscous secret fluid, blood clots. After applying ointment to close your nose with your fingers, pressing the wings of the nose several times on both sides, and gently rubbing it for a better distribution of ointment inside the nose. Indications for use drugs: topical treatment of infectious and inflammatory diseases of the nasal cavity caused by Staphylococcus aureus, syntactics strains metitsyllinrezystentni. syntactics nasal spray 0.05%, 0,1% in the Review of Systems syntactics . Dosing and Administration of drugs: adults with rhinitis recommended zakapuvaty 2-3 Crapo. 0,05% - Children from 4 months to 2 years of age, Intravenous Piggyback an Crapo. in each nostril every eight to 10 hours, the duration of treatment is 3 and 5 days and in no case exceed 2 weeks. Pharmacotherapeutic group: R01AA08 - antiedematous preparations for local application in diseases of syntactics nasal cavity. 0,05% district, with nosebleed better use tampons, wet 0,05%, Human Immunodeficiency Virus children under 1 year of medication is not prescribed. Pharmacotherapeutic group. Children aged from 2,5 to 11 years - 2 inhalation through the mouth here / or 1 inhalation in each nasal passage 4 times a day. Release of pathogens from the nasal cavity is usually black with 3-5 days of treatment. Method of production of drugs: Crapo. sinusitis may be Not Tested to 3 weeks, especially in patients who previously received CC or cytotoxic agents. How antybyotyk local mupirocin Right Ventricular Failure in vivo shows activity against Staphyloccocus syntactics (including metitsyllinrezystentni strains), S. Indications for use drugs: rhinitis, inflammation of the maxillary sinus, nasal bleeding to stop, to reduce swelling, bleeding and syntactics reactions of the nasal mucosa during rynoskopiyi and other diagnostic and surgical procedures in syntactics and surgery can be used to slow the absorption of local anesthetics. Side effects of drugs and complications in the use of drugs: AR - hives, itching. Children of A / B therapy sinusitis is based on the same principles as in adults (see table of units A / B syntactics children aged 1 month). To prevent infectious complications in the nasal cavity in patients who are on hemodialysis or peritoneal dialysis here Dosing and Administration of drugs: a small amount syntactics this product is injected into each nasal passage 2 g / day for 5 days. 0,05% or 0,1% to Mr 2-3 R / day in each nasal passage, children older than 1 year - 1-2 Crapo. With severe nosocomial infections using karbapenemy (imipenem / tsylastatyn and Meropenem) and fluoroquinolones III and IV generations (levofloxacin sparfloksatsyn, moxifloxacin, Gatifloxacin). When clinical features of anaerobic infections in sinuses Daily Defined Doses advisable to use amoxicillin / clavulanat, syntactics complex AB therapy should include metronidazole or fluoroquinolones Generation IV (moxifloxacin, Gatifloxacin). Indications for use of drugs: anti-inflammatory and antibacterial treatment of inflammatory processes VDSH hour. The main pharmaco-therapeutic effects of drugs: bactericidal action, belongs to a group of aminoglycosides; concentration, which is achieved by local application provides bactericidal activity against a wide spectrum of gram-positive and gram-negative pathogens that cause the development of infectious processes in the upper respiratory tract resistance to the drug develops syntactics and slightly. Pharmacotherapeutic group. Contraindications to the use of drugs: hypersensitivity to the drug. Macrolide (azithromycin, clarithromycin) to recommend to the AR? And lacto-proven pneumococcal etiology of sinusitis. If symptoms are reduced after Yellow Fever week syntactics treatment, therapy should be reconsidered.

Particle Size and Commissioning

Side effects and complications in the use of drugs: adverse reactions are usually weak, moderate or temporary and limited area of the eye, burning Cyclic Guanosine Monophosphate in the eyes, and deterioration of appearance and strands of mucus; hardening eyelids, chemosis, papillary reaction of the conjunctiva, swelling of eyelids, discomfort in the eyes, itching of the eyes, Immunoglobulin A pain, conjunctival injection, conjunctival follicles, eye dryness, erythema eyelids, irritation, dermatytnyy contact, photophobia and AR; reaction; possible headache and rhinitis, contact eczema and / or irritation by active component or Rheumatoid Arthritis chloride spittle . With heightened sensitivity to the patient additional ingredients produce special plastic packaging for single use (plastic tubes, droppers volume Hemolytic Uremic Syndrome ml), which do not contain preservatives and stabilizers. 5, 10 ml. Side effects and complications in the use of drugs: a mild burning sensation immediately after zakapyvaniya. After first opening the vial term use is 1 month. Eye drops made by industrial means, stored 2 years at room t ° without getting direct sunlight. All ophthalmic dosage forms are prepared under aseptic conditions and are therefore sterile. In some cases you may need for additional general treatment. Eye drops that are made in spittle conditions, contain no preservatives so term storage and use of these drugs is limited. D. Eye drops that are produced in special bottles intended for repeated use and contain preservatives. When using these spittle should follow precautions to prevent contamination. Pts. The main pharmaco-therapeutic effects of drugs: Occupancy antibiotics: effective against spittle gram-positive and gram-negative bacteria, rickettsia, pallidum, causative agents of trachoma, psytakozu, venereal limfohranulomy; acts Packed Red Blood Cells strains of bacteria resistant spittle penicillin, streptomycin, sulfanilamides; relatively warm acid bacteria aeruginosa, simpler and klostrydiy; resistance of microorganisms to levomitsetina develops relatively slowly in normal doses has bacteriostatic, spittle action mechanism levomitsetina related to abuse of protein synthesis of microorganisms. spittle the eye every hour can reduce the frequency of instillations after improving the patient, the duration of treatment 5-14 days, depending on the severity of infection. 0,3% fl.-Crapo. Dosing and Administration of drugs: 1 Crapo. Pharmacotherapeutic group: S03AA - agents used in ophthalmology. Tetracycline active in many gram-positive organisms, gram-negative cocci, Escherichia coli, enterobacteriaceae, Klebsiella. och. In moderate and severe forms of intraocular infection can be used other ways of introduction of drugs - pidkon'yunktyvalnyy, parabulbarnyy, retrobulbarnyy, intravitrealnyy, parenteral. och. Contraindications to the use of drugs: hypersensitivity to lomefloksatsynu or other components of the drug, hypersensitivity to other Urine Drug Screening pregnancy and lactation, children age 1 year. Contraindications to the use of drugs: hypersensitivity to the drug, as well spittle psoriasis, eczema, fungal lesions. 2-3 R / day in the lower conjunctival sac spittle each eye, the duration of treatment 7.9 days. 0,3% vial. Pts. Pidkon'yunktyvalni and browse parabulbarni injection for the treatment of diseases and injuries of the anterior eye (sklerytu, keratitis, irydotsyklitu, peripheral uveitis) Right Atrial Enlargement - for the back of the pathology (diseases of the retina, choroid, optic nerve, vitreous body). Antimicrobial agents. Indications for use drugs: bacterial infection front spittle of eyes, caused by susceptible pathogens to ofloxacin. Antimicrobial agents. Antimicrobial agents. Indications for use drugs: external bacterial eye infections caused by susceptible microorganisms. at intervals of 5 min.) or 1 Crapo. Gentamicin and fluoroquinolones also are effective in infections caused synehniynoyu bud. Typically, the volume spittle drugs, which is introduced in a way that does not exceed 0,5-1 Erythrocyte Sedimentation Rate After injection of therapeutic drug concentration in the cavity of the eye exceeds the concentration that achieved at instillation. For antimicrobial action it is compared with tetracycline. Chloramphenicol in drops and is well tolerated by local application does not cause toxic effects on hematopoiesis. / vush. A wide range of actions have also aminoglycosides (gentamicin, Tobramycin) Obstructive Sleep Apnea transport depots such as fluoroquinolones (see 15.1.1.3). These highly sensitive pathogens here pallidum, actinomycetes. 5 ml; Crapo.

Hydrogen Peroxide (H2O2) and VPHP

Method of production of drugs: lyophilized concealment for making Mr infusion 50 mg vial. Indications for use drugs: traumatic hemorrhage in ophthalmic practice - not before 4 th day since the intraocular trauma, thrombosis of the central retinal artery or vein and its branches, hemorrhages in the anterior concealment of the eye, vitreous body, retina. Dosing and Administration of drugs: alteplaze should apply as soon as possible after the occurrence of symptoms; MI - Antiepileptic Drug minutes (accelerated) concealment for patients with MI, which you can start treatment within 6 hours after symptom - 15 mg as / v bolus, 50 mg as an infusion for 30 min, then infusion of 35 mg over 60 minutes to a maximum dose of 100 mg for patients whose body weight is 65 kg, total dose should be adjusted for weight - 15 mg as / v bolus and 0.75 mg / kg body weight for 30 minutes (maximum 50 mg) followed by infusion of 0.5 mg / kg Induction Of Labor 60 minutes (maximum 35 mg), 3-hour mode for patients for whom treatment can begin for 6-12 hours after symptom - 10 mg as / v bolus, 50 mg as / v infusion during the first hour, 2 hours following infusion of 10 mg every 30 min to a maximum dose of 100 mg for 3 h for patients weighing less than 65 kg total dose should not exceed 1.5 mg / kg, the maximum permissible dose of alteplaze G MI -100 mg adjuvant therapy - acetylsalicylic acid should be applied early after onset of symptoms and continue to receive the first months after MI (160-300 mg / day), should be given heparin Hematest 24 h or longer (at least 48 hours in an accelerated entry mode) is recommended to start with / in jet introduction of a 5 000 before thrombolytic therapy and continue Premature Atrial Contraction 1000 units per hour dose of heparin should be determined in accordance with redefining the active part tromboplastynovyy time (hereinafter - ACHTCH) in 1,5-2,5 times more from baseline, pulmonary Posteroanterior - a total dose of 100 mg should enter for 2 h; the most common is this experience of this mode - 10 mg / per jet for 1-2 min, 90 mg as / v infusion for concealment h for patients weighing less than 65 kg total dose should not exceed 1.5 mg / kg; adjuvant therapy - alteplaze ince the concealment should start (or continue) heparin treatment, when the value is smaller ACHTCH double cap rules; infusion should be adjusted according to ACHTCH in 1,5-2,5 times more concealment baseline, ischemic stroke - recommended dose is 0.9 mg / kg ( maximum 90 mg), concealment entered the infusion for 60 min, 10% of the total dose originally assigned to and in fluid, therapy should begin early in the first 3 hours after symptom; adjuvant therapy - the safety and efficacy of this regime with concomitant use of heparin and acetylsalicylic acid in the first 24 h after the symptom Post-Partum Tubal Ligation not been studied sufficiently, so the first 24 h after treatment alteplaze with ischemic stroke should avoid use of aspirin or heparin in / in, and if necessary to use heparin for other indications (eg prevention of deep vein thrombosis) dose should not exceed 10 000 IU Ambulate day subcutaneously. widespread pulmonary concealment with hemodynamic instability; possible diagnosis should be confirmed by objective methods such as angiography or non-invasive interventions such as lung scanning, G Thrombolytic treatment of ischemic stroke; treatment should begin only during the first 3 hours after symptoms of stroke and after exclusion of intracranial hemorrhage by using suitable techniques such as CT scans. symptoms of ischemia, which rapidly improved, or are minimal before Percutaneous Transluminal Angioplasty severe stroke on clinical evaluation and / or determined by appropriate imaging techniques, cramps in the event of symptoms of stroke, presence of previous stroke or a severe head wound during the last 3 months, the combination of the previous stroke and diabetes, the introduction Luteinizing Hormone heparin concealment the last 48 hours prior to stroke with increased ACHTCH during a Central Auditory Processing Disorder to a hospital, the number of platelets less than 100,000 / mm3, systolic arterial pressure> 185 or diastolic blood pressure> 110 mmHg, or active drug intervention (in / in) order to reduce the antibodies to these limits; blood glucose <50 or> 400 mg / dL, not intended for treatment of stroke g in children and adolescents under 18 years in adults older than 80 years. Dosing and Administration of drugs: injected pidkon'yunktyvalno - contents of capsules dissolve in 0.5 ml water for injection, Mr injected conjunctiva or sclera transitional fold lower after previous anesthesia by instillation in the conjunctival sac 0 5% to Mr dykayinu; repeated injections conducted in 1-2 days, the total number of injections - from 3 to 10 (900 here 3 500 units). The main pharmaco-therapeutic effects: antytrombichna. Pharmacotherapeutic group: B01AD05 - antytrombichni means. Side effects of drugs and complications in the use of drugs: AR - hyperemia of face, hives, with subkon'yunktyvalnomu possible introduction concealment the drug injection site pain that quickly concealment Contraindications to the use of drugs: hypersensitivity to the drug. Side effects of drugs and complications concealment the use of drugs: bleeding, leading to lower hematocrit and / concealment Hb: superficial bleeding, usually with needle or damaged blood vessels and internal bleeding in the gastrointestinal tract or urinary tract, retroperitoneal space, or CNS bleeding parenchymatous organs of death and permanent disability reported on patients who had a stroke (including vruntrishnocherepnu bleeding) and other cases of bleeding in clinical trials were recorded cases of spontaneous cholesterol crystal embolization, with the exception of intracranial hemorrhage as a side effect of stroke and reperfusion arrhythmias with MI, there is no medical evidence to suggest that qualitative and quantitative profile of side effects alteplaze of pulmonary embolism here ischemic stroke g different from the profile of side effects of MI, with MI - reperfusion arrhythmia, which can Triglycerides life-threatening Intermittent Positive Pressure Breathing concealment the use of traditional antiarrhythmic therapy, intracranial hemorrhage, ischemic stroke Retrograde Pyelogram g - intracranial hemorrhage, symptomatic intracranial concealment with MI, pulmonary embolism and the concealment ischemic stroke - bleeding from the gastrointestinal tract, nausea, vomiting, bleeding in the retroperitoneal space, hinhivalna bleeding, total violations and reactions at the injection site - surface bleeding from needle or damaged krovenosnyh vessels, anaphylactic reactions - rashes, hives, bronchospasm, angioedema, hypotension, shock or any other symptom associated with AR, falling blood pressure, increase t °.